World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
76
Citations
16148
World Ranking
1942
National Ranking
135

Gerhard Moldenhauer publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Gerhard Moldenhauer sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 220 publications — 41st percentile

41% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Gerhard Moldenhauer D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Gerhard Moldenhauer sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 76 D-Index — 62nd percentile

62% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Gerhard Moldenhauer is affiliated with the German Cancer Research Center in Germany. Their research primarily focuses on the field of Medicine, with significant contributions in various subfields including Oncology, Radiology, Nuclear Medicine and Imaging, Immunology, Epidemiology, and Genetics.

Their published work demonstrates engagement with key topics such as Monoclonal and Polyclonal Antibodies Research, Cytokine Signaling Pathways and Interactions, CAR-T cell therapy research, Immunotherapy and Immune Responses, Hepatitis B Virus Studies, Virus-based gene therapy research, and Hepatitis C virus research.

Recent notable papers authored or co-authored by Gerhard Moldenhauer include:

  • Co-Stimulatory Bispecific Antibodies Induce Enhanced T Cell Activation and Tumor Cell Killing in Breast Cancer Models, 2021, Frontiers in Immunology
  • T-cell engager antibodies enable T cells to control HBV infection and to target HBsAg-positive hepatoma in mice, 2021, Journal of Hepatology
  • A new reliable and highly specific monoclonal antibody to detect the C-terminal region of silencer of cytokine signaling 1, 2021, European Journal Of Haematology
  • Combination of two monoclonal antibodies with SOCS1 N- and C-terminal binding sites to address SOCS1 status in B cells and B-cell lymphoma, 2021, European Journal Of Haematology

Gerhard Moldenhauer frequently publishes in the following venues:

  • European Journal Of Haematology
  • Frontiers in Immunology
  • Journal of Hepatology

Collaborative work involves regular co-authorship with researchers such as Marten Meyer, Nadja Bulbuc, Frank Momburg, Stephanie E. Weissinger, and Malena Zahn.

Best Publications

  • Of mice and men: hybridoma and recombinant antibodies

    M Little;S.M Kipriyanov;F Le Gall;G Moldenhauer

  • VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma

    B. M. Beckermann;Georgios Kallifatidis;Georgios Kallifatidis;A. Groth;A. Groth;D. Frommhold

  • Bispecific tandem diabody for tumor therapy with improved antigen binding and pharmacokinetics.

    S M Kipriyanov;G Moldenhauer;J Schuhmacher;B Cochlovius

  • Loss of EpCAM expression in breast cancer derived serum exosomes: role of proteolytic cleavage.

    Anne-Kathleen Rupp;Christian Rupp;Sascha Keller;Jan C. Brase

  • Sulforaphane targets pancreatic tumour-initiating cells by NF-κB-induced antiapoptotic signalling

    Georgios Kallifatidis;Vanessa Rausch;Bernd Baumann;Anja Apel

  • High level production of soluble single chain antibodies in small-scale Escherichia coli cultures

    Sergey M. Kipriyanov;Gerhard Moldenhauer;Melvyn Little

  • HLA-DM Acts as a Molecular Chaperone and Rescues Empty HLA-DR Molecules at Lysosomal pH

    Harald Kropshofer;Sven O Arndt;Gerhard Moldenhauer;Günter J Hämmerling

  • Sulforaphane increases drug-mediated cytotoxicity toward cancer stem-like cells of pancreas and prostate.

    Georgios Kallifatidis;Georgios Kallifatidis;Sabrina Labsch;Sabrina Labsch;Vanessa Rausch;Vanessa Rausch;Juergen Mattern;Juergen Mattern

  • Therapeutic Potential of Amanitin-Conjugated Anti-Epithelial Cell Adhesion Molecule Monoclonal Antibody Against Pancreatic Carcinoma

    Gerhard Moldenhauer;Alexei V. Salnikov;Sandra Lüttgau;Ingrid Herr

  • CD19 monoclonal antibody HD37 inhibits anti-immunoglobulin-induced B cell activation and proliferation.

    A Pezzutto;B Dörken;P S Rabinovitch;J A Ledbetter

  • Metalloprotease-Mediated Tumor Cell Shedding of B7-H6, the Ligand of the Natural Killer Cell–Activating Receptor NKp30

    Eva Schlecker;Nathalie Fiegler;Annette Arnold;Peter Altevogt

  • Bispecific CD3 × CD19 diabody for T cell-mediated lysis of malignant human B cells

    Sergey M. Kipriyanov;Gerhard Moldenhauer;Gudrun Strauss;Melvyn Little

  • HD39 (B3), a B lineage-restricted antigen whose cell surface expression is limited to resting and activated human B lymphocytes.

    B Dörken;G Moldenhauer;A Pezzutto;R Schwartz

  • Di-, tri- and tetrameric single chain Fv antibody fragments against human CD19: effect of valency on cell binding.

    Fabrice Le Gall;Sergey M. Kipriyanov;Gerhard Moldenhauer;Melvyn Little

  • Efficient Inhibition of Intra-Peritoneal Tumor Growth and Dissemination of Human Ovarian Carcinoma Cells in Nude Mice by Anti-L1-Cell Adhesion Molecule Monoclonal Antibody Treatment

    Matthias J.E. Arlt;Ilse Novak-Hofer;Daniela Gast;Verena Gschwend

  • Dietary polyphenol quercetin targets pancreatic cancer stem cells.

    Wei Zhou;Georgios Kallifatidis;Bernd Baumann;Vanessa Rausch;Vanessa Rausch

  • Differential expression of Ia and Ia-associated invariant chain in mouse tissues after in vivo treatment with IFN-gamma.

    F Momburg;N Koch;P Möller;G Moldenhauer

  • Dimeric and multimeric antigen binding structure

    Fabrice Le Gall;Sergey Kipriyanov;Uwe Reusch;Gerhard Moldenhauer

  • Mediastinal lymphoma of clear cell type is a tumor corresponding to terminal steps of B cell differentiation.

    Peter Möller;Peter Möller;Gerhard Moldenhauer;Gerhard Moldenhauer;Frank Momburg;Frank Momburg;Birgit Lämmler;Birgit Lämmler

  • Epithelium-specific surface glycoprotein of Mr 34,000 is a widely distributed human carcinoma marker.

    G. Moldenhauer;F. Momburg;P. Möller;R. Schwartz

Frequent Co-Authors

Melvyn Little
Melvyn Little German Cancer Research Center
Günter J. Hämmerling
Günter J. Hämmerling German Cancer Research Center
Peter Altevogt
Peter Altevogt German Cancer Research Center
Frank Momburg
Frank Momburg German Cancer Research Center
Annemarie Poustka
Annemarie Poustka German Cancer Research Center
Markus W. Büchler
Markus W. Büchler Champalimaud Foundation
Volker Schirrmacher
Volker Schirrmacher German Cancer Research Center
Bernd Arnold
Bernd Arnold German Cancer Research Center
Adelheid Cerwenka
Adelheid Cerwenka Heidelberg University
Anthony D. Ho
Anthony D. Ho University Hospital Heidelberg

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Immunology often opens doors to diverse healthcare and research careers. For many, transitioning within the nursing field complements an immunology background. For instance, experienced nurses interested in specialized patient care can explore the pathway from fnp to acute care np, gaining advanced skills to address critical illnesses.

Students who are eager to fast-track their nursing careers might consider enrolling in a nurse practitioner accelerated program. These programs cater to those seeking efficiency without compromising on quality education, making them ideal for dedicated learners.

For individuals without prior nursing experience but an interest in healthcare, online nursing programs for non nurses provide an accessible starting point. These programs offer flexible learning options that accommodate diverse schedules and career goals.

Applicants seeking a simpler entry into nursing education might explore the easiest accelerated nursing programs to get into. While more accessible, these programs still maintain solid curriculums that prepare students for rewarding careers in healthcare and immunology-related fields.

Best Scientists Citing Gerhard Moldenhauer

Trending Scientists

Recently Published Articles